Investigating the impact of obstructive sleep apnea on heart health in young adults
Obstructive Sleep Apnea and Associated Pathologic Cardiovascular Phenotypes in Young Individuals: A Comprehensive and Longitudinal Analysis of At-Risk College-Aged Students
This study is looking at how obstructive sleep apnea affects heart health in young adults, especially athletes, to see if treating sleep apnea can help improve any heart issues that might come up.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11045723 on NIH RePORTER |
What this research studies
This research focuses on understanding how obstructive sleep apnea (OSA) affects cardiovascular health in young, college-aged individuals. By analyzing a population that includes at-risk athletes, the study aims to uncover the early cardiovascular changes associated with OSA and whether treatment can reverse these changes. Participants will undergo assessments to evaluate their cardiovascular function and the presence of OSA, providing valuable insights into the relationship between these conditions. The research seeks to fill gaps in knowledge regarding OSA's impact on younger populations, which has been largely overlooked in previous studies.
Who could benefit from this research
Good fit: Ideal candidates for this research include college-aged individuals, particularly those involved in athletics or with risk factors for obstructive sleep apnea.
Not a fit: Patients who are older or have advanced cardiovascular disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment of cardiovascular issues related to obstructive sleep apnea in young adults.
How similar studies have performed: While there has been significant research on OSA in older populations, this approach focusing on younger individuals is relatively novel and has not been extensively tested.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Kim, Jonathan Ho-Youn — Emory University
- Study coordinator: Kim, Jonathan Ho-Youn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.